Moving averages
SMA 200$1.39-31.53%
Company profile
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$241.86M
P/E ratioNone
EPS$-0.12
Beta0.235
Dividend yield0.00%
52-week high$3.32
52-week low$0.82
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 43
CGC
Canopy Growth Corporation
RSI 36
BFRI
Biofrontera Inc
RSI 60
TLRY
Tilray Brands Inc - Class 2
RSI 33
LNTH
Lantheus Holdings Inc
RSI 43
ACB
Aurora Cannabis Inc
RSI 53
BCRX
Biocryst Pharmaceuticals Inc
RSI 30
INM
InMed Pharmaceuticals Inc
RSI 37
ORGO
Organogenesis Holdings Inc - Class A
RSI 29
ZTS
Zoetis Inc - Class A
RSI 57
RSI alerts for AKBA
Get an email the moment Akebia Ther crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 3:37 AM EDT